Lyme Disease Treatment Market
Opportunity And Analysis 2026
-
Trends,
Lyme disease is an infectious disease, caused due to the bacterium – Borrelia burgdorferi,
which is transmitted to humans through bites of infected adult black-legged ticks. Most human
infections are caused by bites of nymphs (immature tick). Ticks can attach to any part of the
human body and can transmit the infection, if attached to the host body for 36 to 48 hours.
Blacklegged ticks are responsible for spreading Lyme disease in the northeastern, mid-Atlantic,
and north-central areas of the U.S. However, western black-legged ticks spread Lyme disease in
the regions along the Pacific Coast. These regions are thus, expected to witness rapid growth of
the market for Lyme disease treatment in the near future.
Request PDF Brochure Of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/862
The early symptoms associated with Lyme disease include fever, headaches, chills, fatigue,
muscle and joint aches, swollen lymph nodes, and characteristic skin rash (erythema migrans).
According to the Centers for Disease Control and Prevention (CDC), erythema migrans affects
around 70% to 80% of infected people, worldwide. However, untreated Lyme disease can lead
to further discomfort, which includes intermittent pain in muscles, tendons, joints, and bones,
coupled with severe headaches, neck stiffness, arthritis with severe joint pain, swelling in knees,
facial palsy, increased heart palpitations or an irregular heartbeat, nerve pain, and inflammation
of the brain and spinal cord.
Lyme carditis is a rare complication in Lyme disease, which occurs when infection invades the
tissue of the heart. This can interfere with normal heart rhythm resulting in mild, moderate, or
severe heart blockage. Patients may experience palpitations, lightheadedness, blackouts, chest
pain, and dyspnea. According to the National Surveillance Data, done by National Notifiable
Disease Surveillance System (NNDSS), between 2001 and 2010, Lyme carditis affected around
1% of patients suffering from Lyme disease, in the U.S. Lyme carditis can be treated with
intravenous or oral antibiotics, preferably ceftriaxone. However, some patients might require
implantation of a temporary or permanent pacemaker, depending upon the severity of infection.